Die vasomotorische Rhinopathie

Aktueller Stand der Therapie
  • M.W. Winter
Part of the HNO Praxis heute book series (HNO, volume 24)


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Andersson KE, Bende M (1984) Adrenoreceptors in the control of human nasal mucosal blood flow. Ann Otol Rhinol Laryngol 93:179–182PubMedGoogle Scholar
  2. 2.
    AWMF online-Leitlinien: Die nasale Hyperreaktivität, Leitlinie Nr. 017/058. AWMF/ll/nahy-t01.htmGoogle Scholar
  3. 3.
    Bende M, Loth S (1986) Vascular effects of topical oxymetazoline on human nasal mucosa. J Laryngol Otol 1986; 100: 285–88PubMedGoogle Scholar
  4. 4.
    Black MJ, Remsen KA (1980) Rhinitis medicamentosa. Can Med Assoc J 122: 881–884PubMedGoogle Scholar
  5. 5.
    Borum P, Mygind N, Larsen FS (1979) Intranasal ipratropium: a new treatment for prenennial rhinitis. Clin Otolaryngol 4: 407–411PubMedGoogle Scholar
  6. 6.
    Burks TF, Buck SH, Miller MS (1985) Mechanisms of depletion of substance P by capsaicin. Fed Proc 44: 2531–2534PubMedGoogle Scholar
  7. 7.
    Dong Z, Sun SY, Bu GX (1991) Anterior ethmoidal electrocoagulation for treatment of vasomotor rhinitis. Chin J Otorhinolaryngol 26: 358–359Google Scholar
  8. 8.
    Dykewicz MS, Fineman S, Skoner DP et al. (1998) Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and mmunologogy. Ann Allergy Asthma Immunol 81: 478–518PubMedGoogle Scholar
  9. 9.
    Eccles R (1992) Nasal airway resistance and nasal sensation of airflow. Rhinol Suppl 14: 86–90PubMedGoogle Scholar
  10. 10.
    Heppt W (Hrsg) (1995) Zytologie der Nasenschleimhaut. Springer, Berlin Heidelberg New YorkGoogle Scholar
  11. 11.
    Iguchi Y, Yao K, Okamoto (2002) A ccharacteristic protein in nasal discharge differentiating non-allergic chronic rhinosinusitis from allergic rhinitis. Rhinologty 40: 13–17Google Scholar
  12. 12.
    Ishii T, Toriyama M (1972) Acetylcholinesterase activity in the vasomotor and secretory fibers of the nose. Arch Klein Exp Ohr Kehlkopfheilkd 201: 1–10Google Scholar
  13. 13.
    Jaradeh SS, Smith TL, Torrico L, Prieto TE, Loehrl TA, Darling RJ, Toohill RJ (2000) Autonomic nervous system evaluation of patients with vasomotor rhinitis. Laryngoscope 110: 1828–1831PubMedGoogle Scholar
  14. 14.
    Kaiser HB, Findlay SR, Georgitis JW, Grossman J, Ratner PH, Tinkelman DG (1995) Longterm treatment of perennial allergic rhinitis with ipratropium bromide nasal spray 0,06%. J Allergy Clin Immunol 95: 1128–32PubMedGoogle Scholar
  15. 15.
    Kim KS, Kim SS, Yoon JH, Han JW (1998) The effect of botulinumtoxin type A injection for intrinsic rhinitis. J Laryngol Otol 112: 248–251PubMedGoogle Scholar
  16. 16.
    Kimmelman CP, Ali GHA (1986) Vasomotor rhinitis. Otolaryngol Clin North Am 19: 65PubMedGoogle Scholar
  17. 17.
    Kubo N, Kumazawa T, Yamashita T et al. (1989) Functional disturbancde of the sympathetic nerve in experimentally-induced nasal hypersensitivity. Acta Otolaryngol (Stockh) 463: 5–13 (Suppl)Google Scholar
  18. 18.
    Lin PY, Cheng CY, Wu CC, Yen MY, Wang SJ, Liao KK, Lee SM (2001) Bilateral neurotrophic keratopathy complicating Vidian neurectomy. Am J Ophthalmol 132: 106–108CrossRefPubMedGoogle Scholar
  19. 19.
    Loehrl TA, Smith TL, Darling RJ et al. (2002) Autonomic dysfunction, vasomotor rhinitis, and extraeosphageal manifestations of gastroesophageal reflux. Otolaryngol Head Neck Surg 126: 382–387CrossRefPubMedGoogle Scholar
  20. 20.
    Lung MA, Wang JCC (1989) Autonomic nervous control of nasal vasculature and airflow resistance in the anaesthetized dog. J Physiol 419:121–139PubMedGoogle Scholar
  21. 21.
    Lung MA (1995) The role of the autonomic nerves in the control of nasal circulation. Biol Signals 4: 179–185PubMedGoogle Scholar
  22. 22.
    Malcolmson K (1959) The vasomotor activities of the nasal mucous membrane. J Laryngol Otol 73: 73–98Google Scholar
  23. 23.
    Malm L, Wihl JA, Lamm CJ Lindquist N (1981) Reduction of methacholine-induced nasal secretion by treatment with a new inhaled topical streoid in perennial non-allergic rhinitis. Allergy 36: 209–214PubMedGoogle Scholar
  24. 24.
    McCaffrey T, Kern E (1979) Response of nasal airwa resistance to hypercapnia and hypoxia in man. Ann Otol Rhinol Laryngol 8: 47–252Google Scholar
  25. 25.
    Mygind N (ed) (1979) Perennial rhinitis. In: Nasal allergy, 2nd edn. Blackwell, Oxford, pp 224–232Google Scholar
  26. 26.
    Nomura Y, Matsuura T (1972) Distribution and clinical significance of the autonomic nervous system in the human nasal mucosa. Acta Otolaryngol 73: 493–501PubMedGoogle Scholar
  27. 27.
    Pontel P (1984) Toxicity of the over-the counter stimulants. J Am Med Assoc 252: 1898–1903Google Scholar
  28. 28.
    Prasanna A, Murthy PSN (1997) Vasomotor rhinitis and sphenopalatine ganglion block. J Pain Symptom Manage 13: 332–338CrossRefPubMedGoogle Scholar
  29. 29.
    Preece M, Eccles R. (1993) The effect of pressure and warmth applied to the axilla on unilateral nasal airway resistance and facial skin temperature. Acta Otolaryngol 113: 777–781PubMedGoogle Scholar
  30. 30.
    Rao S, Potdar A (1970) Nasal airflow with body in various positions. J Appl Physiol 28: 162–171PubMedGoogle Scholar
  31. 31.
    Riechelmann H, Davris S, Bader D (1993) Behandlung der perennialen nichtallergischen Rhinopathie mit Capsaicin. HNO 41: 475–479PubMedGoogle Scholar
  32. 32.
    Ring J (Hrsg) (1992) Angewandte Allergologie, 2. Aufl. MMV Medizinverlag, MünchenGoogle Scholar
  33. 33.
    Rohrbach S, Olthoff A, Laskawi R, Giefer B, Bötz W (2001) Botulinum toxin type A induces apoptosis in nasal glands of guinea pigs. Ann Otol Rhinol Laryngol 110: 1045–1050PubMedGoogle Scholar
  34. 34.
    Rucci L, Borghi Cirri MB, Masini E, Fini Storchi O (1985) Vidian nerve resection in chronic hypertrophic non allergic rhinitis: effects on histamine content, number and rate of degranulation processes of mast cells in nasal mucosa. Rhinology 23: 309–314PubMedGoogle Scholar
  35. 35.
    Rucci L, Masini E, Arbi Riccardi R et al. (1989) Vidian nerve resection, histamine turnover and mucosal mast cell function in patients with chronic hypertrophic non-allergic rhinitis. Agents Actions 28: 224–230CrossRefPubMedGoogle Scholar
  36. 36.
    Saavedra-Delgado AMP, Mathews KP, Pan PM, Kay DR, Muilenberg ML (1980) Dose-response studies of the suppression of whole blood histamine and basophil counts by prednisone. J Allergy Clin Immunol 66: 464–71PubMedGoogle Scholar
  37. 37.
    Seebohm PM (1990) Allergic and nonallergic rhinitis. In: English GM (ed) Otolaryngology. Lippincott, PhiladelphiaGoogle Scholar
  38. 38.
    Segal S, Shlamkovitch N, Eviatar E, Berenholz L, Sarfaty S, Kessler A (1999) Vasomotor rhinitis following trauma to the nose. Ann Otol Rhinol Laryngol 108: 208–210PubMedGoogle Scholar
  39. 39.
    Shaari CM, Sanders I, Wu BL, Biller HF (1993) A new target for botulinum toxin therapy in the head and neck: the autonomic nervous system. Presaented at the American Society of Head and Neck Surgery meeting, Los Angeles, Calif., April 21Google Scholar
  40. 40.
    Shaari CM, Sanders I, Wu BL, Biller HF (1995) Rhinorrhea is decreased in dogs after nasal application of botulinum toxin. Otolaryngol Head Neck Surg 112: 566–571PubMedGoogle Scholar
  41. 41.
    Sun SY, Dong Z, Bu GX (1991) Distribution and significance of nasal glands. Chin J Otolaryngol 26: 96–98Google Scholar
  42. 42.
    Tasman AJ (2002) Die untere Nasenmuschel: Dysregulation und chirurgische Verkleinerung. Laryngo Rhino Otol 81: 822–838Google Scholar
  43. 43.
    Wihl JA, Petersen BN, Petersen LN, Gundersen G, Bresson K, Mygind N (1985) Effect of the nonsedative H1-receptor antagonist astemizole in perennial allergic and nonallergic rhinitis. J Allergy Clin Immunol 75: 720–727CrossRefPubMedGoogle Scholar
  44. 44.
    Wilson AM, White PS, Gardiner, Nassif R, Lipworth BJ (2001) Effects of leukotriene receptor antagonist therapy in patients with chronic rhinosinusitis in a real life rhinology clinic setting. Rhinology 2001 38: 142–146Google Scholar
  45. 45.
    Wolf G (1988) Neue Aspekte zur Pathogenese und Therapie der hyperreflektorischen Rhinopathie. Laryngol Rhinol Otol 67: 438–445Google Scholar
  46. 46.
    Wolf G, Anderhuber W, Hauser-Kronberger C, Saria A (1995) Die Behandlung der unspezifischen hyperreflektorischen Rhinopathie (vasomotorische Rhinitis) mit Capsaicin. Laryngo-Rhino-Otol 74: 289–293Google Scholar
  47. 47.
    Yue WL (1995) Anterior ethmoidal glycerol rhizotomy for vasomotor rhinitis. ENT-Ear, Nose Throat J 74: 764–767Google Scholar

Copyright information

© Springer Medizin Verlag Heidelberg 2005

Authors and Affiliations

  • M.W. Winter

There are no affiliations available

Personalised recommendations